NEVRO CORP shareholders Q3 2022

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

NEVRO CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 64,000$2,982,0001.09%
PFM Health Sciences, LP 563,560$26,262,0000.95%
Rock Springs Capital Management LP 787,000$36,674,0000.95%
Integral Health Asset Management, LLC 100,000$4,660,0000.90%
ArrowMark Colorado Holdings LLC 1,151,060$53,639,0000.66%
Soleus Capital Management, L.P. 72,000$3,355,0000.46%
HealthCor Management, L.P. 67,600$3,150,0000.39%
EFG Asset Management (North America) Corp. 33,648$1,571,0000.36%
K2 PRINCIPAL FUND, L.P. 63,300$2,950,0000.34%
King Wealth Management Group 22,000$1,025,0000.26%
FOX RUN MANAGEMENT, L.L.C. 13,954$650,0000.25%
PDT Partners, LLC 32,987$1,537,0000.23%
Woodline Partners LP 338,790$15,788,0000.22%
FRED ALGER MANAGEMENT, LLC 933,195$43,487,0000.22%
Perceptive Advisors 150,000$6,990,0000.20%
Bellevue Group AG 260,835$12,155,0000.17%
Polar Asset Management Partners Inc. 224,800$10,476,0000.13%
Olympiad Research LP 4,749$2210.12%
FEDERATED HERMES, INC. 832,930$38,815,0000.11%
ALGERT GLOBAL LLC 35,679$1,663,0000.10%
External links

This page lists NEVRO CORP's shareholders in Q3 2022. To view NEVRO CORP's shareholder history, click here.